BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bismuth subsalicylate; metronidazole; tetracycline hydrochloride and what is the scope of freedom to operate?
Bismuth subsalicylate; metronidazole; tetracycline hydrochloride
is the generic ingredient in two branded drugs marketed by Nostrum Labs Inc and Casper Pharma Llc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Clinical Trials: | 2 |
DailyMed Link: | BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
National Cancer Institute (NCI) | Phase 2 |
See all BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
US Patents and Regulatory Information for BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Casper Pharma Llc | HELIDAC | bismuth subsalicylate; metronidazole; tetracycline hydrochloride | TABLET, CHEWABLE, TABLET, CAPSULE;ORAL | 050719-001 | Aug 15, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Labs Inc | BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | bismuth subsalicylate; metronidazole; tetracycline hydrochloride | TABLET, CHEWABLE, TABLET, CAPSULE;ORAL | 202584-001 | Nov 30, 2018 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |